Year archive

CONTROL BIONICS LIMITED — 2026 filings

All 18 regulatory filings released by CONTROL BIONICS LIMITED (CBL) in 2026, sourced directly from the official regulator.

18 Filings

2026 Period

2026 filings (18)

Filing	Released	Lang
Leading neurotechnology pioneer Prof Nicholas Opie joins CBL 4 pages 248.2KB Board/Management Information	2026-05-13	English
Final Director's Interest Notice - Phillips 2 pages 310.5KB Director's Dealing	2026-05-13	English
Initial Director's Interest Notice - Opie 2 pages 351.6KB Director's Dealing	2026-05-13	English
Proposed issue of securities - CBL 5 pages 18.7KB Share Issue/Capital Change	2026-05-13	English
Control Bionics Strategic Transition Presentation 21 pages 1.5MB Regulatory Filings	2026-05-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 501.8KB Regulatory Filings	2026-04-29	English
First U.S. Letter of Intent for iOS Speech Device Program 2 pages 232.2KB Capital/Financing Update	2026-03-25	English
German Statutory Reimbursement Listing for NeuroNode 3 pages 228.6KB Regulatory Filings	2026-03-03	English
Change of Director's Interest Notice - Rix 2 pages 383.6KB Director's Dealing	2026-03-01	English
Half Yearly Report and Accounts 24 pages 3.7MB Regulatory Filings	2026-02-25	English
Joint venture with NextLevel Assistive Technology 3 pages 239.0KB Regulatory Filings	2026-02-25	English
Investor call presentation 8 pages 909.0KB Interim / Quarterly Report	2026-02-25	English
Investor Briefing 2 pages 232.4KB Regulatory Filings	2026-02-24	English
PRC-Saltillo - Distribution Agreement 2 pages 181.7KB Capital/Financing Update	2026-01-28	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 466.9KB Interim / Quarterly Report	2026-01-27	English
Tobii Dynavox - Distribution Partnership 2 pages 182.2KB Capital/Financing Update	2026-01-26	English
Application for quotation of securities - CBL 6 pages 18.6KB Regulatory Filings	2026-01-01	English
Cleansing notice 1 page 159.7KB Share Issue/Capital Change	2026-01-01	English